MADRIGAL PHARMACEUTICALS
Madrigal Pharmaceuticals is developing novel, high-quality small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases. The Company is targeting treatment of both niche and prevalent indications, including diabetes, dyslipidemia and cardiovascular disease.
MADRIGAL PHARMACEUTICALS
Industry:
Biotechnology Medical Device Pharmaceutical
Founded:
2011-01-01
Address:
Washington, Pennsylvania, United States
Country:
United States
Website Url:
http://www.madrigalpharma.com
Total Employee:
1+
Status:
Active
Contact:
(267) 327-4445
Email Addresses:
[email protected]
Total Funding:
288.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager WordPress Domain Not Resolving Wordpress Plugins Nginx IPv6
Current Advisors List
Current Employees Featured
Founder
Stock Details
Company's stock symbol is NASDAQ:MDGL
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Madrigal Pharmaceuticals
Bay City Capital
Bay City Capital investment in Post-IPO Equity - Madrigal Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-10 | Dominic F. Labriola Joins Madrigal Pharmaceuticals as Chief Data and Analytics Officer |
Official Site Inspections
http://www.madrigalpharma.com Semrush global rank: 2.78 M Semrush visits lastest month: 5.83 K
- Host name: 104.18.23.189
- IP address: 104.18.23.189
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 